37,169 9,174 Cash flows used in investing activities (1,496) (3,955) (13,437) (940) Cash flows used in financing activities (11,459) (276) (9,873) (11,384) Net increase (decrease) in cash and cash
31 March 2017 MB % Cash flow from operating activities 42.19 51.27 (9.08) (17.71) Cash flow used in investing activities (29.12) (59.18) 30.06 (50.79) Cash flow used in financing activities (0.03
acquisitions of property, plant and equipment 12.6 million. (4.3) Cash Flows from Financing Activities The Company has net cash flows used in financing activities for the nine-month period as of September 30
% 25% 1% 28% 25% 3% Other income /(expenses) 15.00 5.09 195% 130.99 23.62 455% Financing cost 0.02 3.58 -99% 4.34 12.03 -64% Corporate Tax 20.58 7.81 163% 99.30 56.44 76% Net profit 81.86 70.04 17
% Cash flow from (used in) operating activities (31.40) 18.44 (49.84) (270.28) Cash flow used in investing activities (57.51) (54.25) (3.26) 6.01 Cash flow from (used in) financing activities (9.41) 70.83
Change THB % Cash flows from operating (8.33) 35.95 (44.28) -123.2% Page5of5 Cash flows from investing (10.98) (16.85) 5.87 -34.8% Cash flows from financing 10.63 (8.13) 18.76 -230.8% Net cash increase
flows from financing 10.64 (8.13) 18.77 -230.87% Net cash increase (decrease) (8.69) 10.97 10.97 (19.66) -179.22% Cash at beginning of period 16.05 116.046.90 16.90 (0.85) -5.03% Cash at end of period
flows from financing 10.64 (8.13) 18.77 -230.87% Net cash increase (decrease) (8.69) 10.97 10.97 (19.66) -179.22% Cash at beginning of period 16.05 116.046.90 16.90 (0.85) -5.03% Cash at end of period
compensation rates of medical staff secured for the future business expansion. Financing Costs The Company and its subsidiary’s financing costs in relation to the loans from financial institutions and related
Cash Equivalent on 1st January 60.6 76.8 Net Cash Provided (Used in) Operating Activities 26.9 24.4 Net Cash Provided (Used in) Investing Activities (0.8) (79.8) Net Cash Provided (Used in) Financing